AR057409A1 - Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas. - Google Patents

Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas.

Info

Publication number
AR057409A1
AR057409A1 ARP060102752A ARP060102752A AR057409A1 AR 057409 A1 AR057409 A1 AR 057409A1 AR P060102752 A ARP060102752 A AR P060102752A AR P060102752 A ARP060102752 A AR P060102752A AR 057409 A1 AR057409 A1 AR 057409A1
Authority
AR
Argentina
Prior art keywords
nrcrd
alkyl
alkenyl
atom
alkynyl
Prior art date
Application number
ARP060102752A
Other languages
English (en)
Spanish (es)
Inventor
Ulrich Bothe
Ulrike Fuhrmann
Carsten Moller
Norbert Schmees
Anja Schmidt
Wolfgang Schwede
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR057409A1 publication Critical patent/AR057409A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
ARP060102752A 2005-06-24 2006-06-27 Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas. AR057409A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030294A DE102005030294A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
AR057409A1 true AR057409A1 (es) 2007-12-05

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102752A AR057409A1 (es) 2005-06-24 2006-06-27 Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas.

Country Status (22)

Country Link
EP (1) EP1899315A1 (ru)
JP (1) JP2008543911A (ru)
KR (1) KR20080018275A (ru)
CN (1) CN101248056A (ru)
AR (1) AR057409A1 (ru)
AU (1) AU2006261049A1 (ru)
BR (1) BRPI0612305A2 (ru)
CA (1) CA2611900A1 (ru)
CR (1) CR9595A (ru)
DE (1) DE102005030294A1 (ru)
DO (1) DOP2006000150A (ru)
EA (1) EA200702604A1 (ru)
EC (1) ECSP078043A (ru)
GT (1) GT200600272A (ru)
IL (1) IL188022A0 (ru)
MX (1) MX2008000070A (ru)
NO (1) NO20080441L (ru)
PE (1) PE20070170A1 (ru)
TW (1) TW200738665A (ru)
UY (1) UY29626A1 (ru)
WO (1) WO2006136462A1 (ru)
ZA (1) ZA200800689B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
IN2014DN10548A (ru) 2012-05-31 2015-08-21 Repros Therapeutics Inc
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
CA2371273A1 (en) * 1999-05-04 2000-11-09 Andrew Fensome Tetracyclic progesterone receptor modulator compounds and methods
ATE346058T1 (de) * 2002-01-14 2006-12-15 Boehringer Ingelheim Pharma Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
AU2003209720A1 (en) * 2002-03-11 2003-09-22 Schering Ag 5-{2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
DE10346939A1 (de) * 2003-10-06 2005-05-19 Schering Ag Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Also Published As

Publication number Publication date
CR9595A (es) 2008-05-05
JP2008543911A (ja) 2008-12-04
NO20080441L (no) 2008-03-07
CN101248056A (zh) 2008-08-20
DE102005030294A1 (de) 2007-01-04
MX2008000070A (es) 2008-03-19
WO2006136462A1 (en) 2006-12-28
KR20080018275A (ko) 2008-02-27
GT200600272A (es) 2007-08-20
ZA200800689B (en) 2009-07-29
ECSP078043A (es) 2008-01-23
AU2006261049A1 (en) 2006-12-28
PE20070170A1 (es) 2007-03-02
EA200702604A1 (ru) 2008-06-30
DOP2006000150A (es) 2006-12-31
EP1899315A1 (en) 2008-03-19
TW200738665A (en) 2007-10-16
CA2611900A1 (en) 2006-12-28
UY29626A1 (es) 2007-01-31
IL188022A0 (en) 2008-03-20
BRPI0612305A2 (pt) 2010-11-03

Similar Documents

Publication Publication Date Title
AR057409A1 (es) Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas.
PE20211795A1 (es) Compuestos heteroaril tetraciclicos
AR030306A1 (es) Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento
AR035305A1 (es) Derivados y analogos del acido 3-arilpropionico, proceso para su preparacion, formulaciones farmaceuticas, uso de los mismos en la elaboracion de medicamentos, y formulacion farmaceutica para usar en la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina
CO6210771A2 (es) Moduladores 2-aminopirimidina del receptor de histamina h4
AR078756A1 (es) Moduladores alostericos positivos (map)
HRP20110498T1 (hr) Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
AR035518A1 (es) Derivados de carboxamida, un procedimiento para su preparacion, un medicamento que los contiene, el u so de los mismos para preparar un medicamento, y un conjunto (kit) que los incluye
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
AR081859A1 (es) Pirimidinas 2,4,6-trisustituidas, composiciones farmaceuticas que las comprenden y su uso en el tratamiento de tumores sensibles a la inhibicion de la cinasa atr
AR062695A1 (es) N-(1- ftalazin -1--il- piperidin -4-il) - amidas como moduladores del receptor ep2
AR082667A1 (es) 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc
PA8517101A1 (es) Derivados de tropano ùtiles en terapia
DOP2005000006A (es) "derivados de sulfonamida para el tratamiento de enfermedades"
ECSP088293A (es) Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado
AR054863A1 (es) DERIVADOS DE 1H-PIRROLO[3, 4-C]PIRAZOL, UN PROCESO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES ASOCIADAS CON EL FACTOR DE COAGULACIoN XA
AR074352A1 (es) Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatitis atopica.
AR067075A1 (es) Derivados de isoxasol - imidazol
UY29802A1 (es) Análogos de la feniletilamina y su uso en el tratamiento del glaucoma
ECSP19020742A (es) DERIVADOS DE CROMANO, ISOCROMANO Y DIHIDROISOBENZOFURANOS COMO MODULADORES ALOSTÉRICOS NEGATIVOS DE mGluR2, COMPOSICIONES Y SU USO
CR20130670A (es) Tetrahidroquinolinas condensadas con cicloalquilo como moduladores de receptores de crth2
AR066604A1 (es) Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente.
AR054519A1 (es) Moduladores no esteroides de receptor de progesterona
AR101566A2 (es) Composición farmacéutica de compuestos heterobicíclicos que contienen nitrógeno

Legal Events

Date Code Title Description
FB Suspension of granting procedure